Health Information Services
- 974.747
- +8.891+0.92%
Goldman Sachs Maintains Neutral on Weave Communications, Raises Price Target to $14.5
10x Genomics Analyst Ratings
BrightSpring Health Raises FY2024 Sales Guidance From $10.45B-10.90B to $11.00B-11.30B (Est $10.831B)
BrightSpring Health Services Non-GAAP EPS of $0.11 Misses by $0.04, Revenue of $2.91B Beats by $190M
GE HealthCare Techs Analyst Ratings
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
Omnicell Cut to Neutral by BofA, Lack of Visibility Into Growth Cited
Teladoc Health Analyst Ratings
Mangoceuticals Regains Full Compliance With Nasdaq Minimum Bid Price Requirement
TechBio Startup Cure51 Selects 10x Genomics Visium HD For New Drug Discovery Initiative; Cure51 Plans To Analyze More Than 1,000 Tumor Samples From Exceptional Cancer Survivors
B of A Securities Downgrades Omnicell to Neutral, Raises Price Target to $57
Omnicell Analyst Ratings
Weave Communications Analyst Ratings
Needham Reiterates Hold on American Well
American Well Analyst Ratings
U.S. stocks closed | The three major indexes all fell, technology stocks weakened, super micro computers plummeted over 32%, AMD dropped over 10% after earnings; overall decline in Donald Trump concept stocks, DJT fell over 22%.
The economic data in the USA is mixed, with the market adjusting down significantly to expectations of a large interest rate cut by the European Central Bank and rate cuts by the United Kingdom in December. US stocks fell across the board, with the chip index dropping by over 3%, nvidia falling by over 3% at one point, Chinese concept stocks dropping by over 2% before halving the decline, and li auto inc turning upwards by nearly 2%.
Spok Declares $0.3125 Dividend
Privia Health Group Reports FY Results
Weave Communications Raises FY2024 Sales Guidance From $201.00M-203.00M to $202.70M-203.70M
Spok GAAP EPS of $0.18 Beats by $0.02, Revenue of $34.87M Beats by $0.57M